These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11069255)

  • 1. Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis.
    Bøyum A; Tennfjord VA; Gran C; Løvhaug D; Oktedalen O; Brandtzaeg P
    J Infect Dis; 2000 Dec; 182(6):1784-7. PubMed ID: 11069255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A; Løvhaug D; Seeberg E; Nordlie EM
    Exp Hematol; 1994 Feb; 22(2):208-14. PubMed ID: 7507861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
    Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P
    Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
    Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
    J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.
    Waring PM; Presneill J; Maher DW; Layton JE; Cebon J; Waring LJ; Metcalf D
    Clin Exp Immunol; 1995 Dec; 102(3):501-6. PubMed ID: 8536364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts.
    Bjerre A; Ovstebø R; Kierulf P; Halvorsen S; Brandtzaeg P
    Clin Infect Dis; 2000 Apr; 30(4):643-7. PubMed ID: 10770723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
    Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
    Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein.
    Gran C; Bøyum A; Johansen RF; Løvhaug D; Seeberg EC
    Blood; 1998 Jun; 91(11):4127-35. PubMed ID: 9596658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease.
    van Woensel JB; Biezeveld MH; Alders AM; Eerenberg AJ; Endert E; Hack EC; von Rosenstiel IA; Kuijpers TW
    J Infect Dis; 2001 Dec; 184(12):1532-7. PubMed ID: 11740728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
    Barth E; Fischer G; Schneider EM; Moldawer LL; Georgieff M; Weiss M
    Cytokine; 2002 Mar; 17(5):275-84. PubMed ID: 12027409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
    Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
    Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
    Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.
    Vermont CL; Hazelzet JA; de Kleijn ED; van den Dobbelsteen GP; de Groot R
    Crit Care; 2006 Feb; 10(1):R33. PubMed ID: 16507164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
    Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
    Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
    Emonts M; Sweep FC; Grebenchtchikov N; Geurts-Moespot A; Knaup M; Chanson AL; Erard V; Renner P; Hermans PW; Hazelzet JA; Calandra T
    Clin Infect Dis; 2007 May; 44(10):1321-8. PubMed ID: 17443469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indices of oxidative-reductive processes in meningococcal infection].
    Vengerov IuIa; Arkhipov AS
    Sov Med; 1979 May; (5):58-61. PubMed ID: 451724
    [No Abstract]   [Full Text] [Related]  

  • 19. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.